DBD - Diebold Nixdorf - Stock Forecast

Technology - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DBD is currently covered by 2 analysts with an average price target of $51.87. This is a potential upside of $6.55 (14.45%) from yesterday's end of day stock price of $45.32.

Diebold Nixdorf's activity chart (see below) currently has 0 price targets and 13 ratings on display. The stock rating distribution of DBD is 38.46% HOLD and 61.54% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.54% with an average time for these price targets to be met of 547.75 days.

Highest price target for DBD is $45, Lowest price target is $19, average price target is $34.5.

Most recent stock forecast was given by MATTHEW BRYSON from WEDBUSH on 15-Feb-2024. First documented stock forecast 18-Nov-2013.

Best performing analysts who are covering DBD - Diebold Nixdorf:

Matt Summerville Paul Condra Paul Coster Jeff Kessler Paul J Chung Matthew Bryson Gil Luria Joshua Elving

Currently out of the existing stock ratings of DBD, 5 are a HOLD (38.46%), 8 are a BUY (61.54%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matthew Bryson (WEDBUSH)

Hold

$40

$7.04 (21.36%)

$25

1 years 2 months 21 days ago
(15-Feb-2024)

5/7 (71.43%)

$6.44 (19.19%)

179

Please subscribe to see the analyst performance score

Matt Summerville (DAVIDSON)

Buy

$29

$-3.96 (-12.01%)

$25

1 years 5 months 26 days ago
(10-Nov-2023)

8/8 (100%)

$7.73 (36.34%)

516

Please subscribe to see the analyst performance score

Paul Chung (JPMORGAN)

Hold

2 years 8 months 24 days ago
(12-Aug-2022)

2/4 (50%)

$3.33 (34.62%)

Please subscribe to see the analyst performance score

Paul Coster (JPMORGAN)

Buy

$16

$-16.96 (-51.46%)

4 years 3 months 15 days ago
(21-Jan-2021)

10/11 (90.91%)

$2.96 (22.70%)

1148

Please subscribe to see the analyst performance score

Paul Condra

$15

$-17.96 (-54.49%)

$15

6 years 9 months 4 days ago
(02-Aug-2018)

4/5 (80%)

$8.3 (123.88%)

1577

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is DBD (Diebold Nixdorf) average time for price targets to be met?

On average it took 547.75 days on average for the stock forecasts to be realized with a an average price target met ratio 61.54

Which analyst has the current highest performing score on DBD (Diebold Nixdorf) with a proven track record?

MATT SUMMERVILLE

Which analyst has the current lower performing score on DBD (Diebold Nixdorf) with a proven track record?

JOSHUA ELVING

Which analyst has the most public recommendations on DBD (Diebold Nixdorf)?

Matt Summerville works at D.A. DAVIDSON and has 11 price targets and 7 ratings on DBD

Which analyst is the currently most bullish on DBD (Diebold Nixdorf)?

Joshua Elving with highest potential upside - $20.57

Which analyst is the currently most reserved on DBD (Diebold Nixdorf)?

Paul Condra with lowest potential downside - -$17.96

Diebold Nixdorf in the News

Olo (OLO) Soars 14.8%: Is Further Upside Left in the Stock?

Olo Inc. OLO shares rallied 14.8% in the last trading session to close at $7.12. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock’s 0.2% gain over the past four weeks. OLO is benefiting from strong growth in...

Wall Street Analysts Think Diebold Nixdorf, Incorporated (DBD) Is a Good Investment: Is It?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let’s see...